RecruitingNCT06218901

Association of Psychological Distress in Patients With Lung Cancer

the Association of Psychological Distress in Patients With Advanced Lung Cancer Treated With Immunotherapy or Targeted Therapy


Sponsor

Shanghai Chest Hospital

Enrollment

500 participants

Start Date

Jan 1, 2016

Study Type

OBSERVATIONAL

Conditions

Summary

Psychological distress is a multi-factorial experience of a psychological, social, spiritual, and/or physical nature that may interfere with one's ability to cope effectively with cancer, physical symptoms and treatment. Psychological distress is common and affects the efficacy and prognosis of patients with lung cancer. The systematic anti-tumor therapy may effectively relieve psychological distress including anxiety, depression, and fatigue in patients with advanced lung cancer, the relief of the psychological distress can in turn improve the therapeutic effect. In summary, this study is to explore the associations of (dynamic) psychological stress with the efficacy and survival of anti-tumor therapy including immunotherapy and targeted therapy for advanced lung cancer patients.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This observational study is examining how psychological distress — including anxiety and depression — is associated with outcomes in patients diagnosed with lung cancer. Researchers want to better understand the emotional burden of the disease to improve supportive care. **You may be eligible if...** - You have a confirmed diagnosis of lung cancer (any type or stage) - You are 18 or older - You are willing to participate in surveys or interviews and can provide informed consent **You may NOT be eligible if...** - You are unwilling to participate in the study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGimmunotherapy
DRUGTargeted Therapy Agent

Locations(1)

Shanghai Chest Hospital

Shanghai, Shanghai Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06218901


Related Trials